Early Results from a Phase 1 Dose Escalation Study Evaluating MS-553, a Novel, Selective Pkcb Inhibitor, in Relapsed or Refractory CLL/SLL Patients
MS-553
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Early Results from a Phase 1 Dose Escalation Study Evaluating MS-553, a Novel, Selective Pkcb Inhibitor, in Relapsed or Refractory CLL/SLL Patients ### Output: MS-553